Clinical implications of T cell exhaustion for cancer immunotherapy

医学 免疫疗法 T细胞 癌症免疫疗法 癌症 免疫系统 免疫检查点 免疫学 癌症研究 内科学
作者
Andrew Chow,Karlo Perica,Christopher A. Klebanoff,Jedd D. Wolchok
出处
期刊:Nature Reviews Clinical Oncology [Nature Portfolio]
卷期号:19 (12): 775-790 被引量:516
标识
DOI:10.1038/s41571-022-00689-z
摘要

Immunotherapy has been a remarkable clinical advancement in the treatment of cancer. T cells are pivotal to the efficacy of current cancer immunotherapies, including immune-checkpoint inhibitors and adoptive cell therapies. However, cancer is associated with T cell exhaustion, a hypofunctional state characterized by progressive loss of T cell effector functions and self-renewal capacity. The ‘un-exhausting’ of T cells in the tumour microenvironment is commonly regarded as a key mechanism of action for immune-checkpoint inhibitors, and T cell exhaustion is considered a pathway of resistance for cellular immunotherapies. Several elegant studies have provided important insights into the transcriptional and epigenetic programmes that govern T cell exhaustion. In this Review, we highlight recent discoveries related to the immunobiology of T cell exhaustion that offer a more nuanced perspective beyond this hypofunctional state being entirely undesirable. We review evidence that T cell exhaustion might be as much a reflection as it is the cause of poor tumour control. Furthermore, we hypothesize that, in certain contexts of chronic antigen stimulation, interruption of the exhaustion programme might impair T cell persistence. Therefore, the prioritization of interventions that mitigate the development of T cell exhaustion, including orthogonal cytoreduction therapies and novel cellular engineering strategies, might ultimately confer superior clinical outcomes and the greatest advances in cancer immunotherapy. T cells are key effectors of immunotherapies that have revolutionized the treatment of cancer; however, chronic exposure to tumour-associated antigens can result in progressive loss of T cell effector functions and self-renewal capacity, a state termed ‘T cell exhaustion’ that is believed to limit the efficacy of immunotherapy. This Review synthesizes the new immunobiological insights that present a more nuanced view beyond T cell exhaustion being entirely undesirable and indicate that this hypofunctional state might be as much a reflection as it is the cause of poor tumour control. Hence, the authors describe how, in certain contexts, interruption of this programme could impair T cell persistence and discuss interventions to mitigate the development of T cell exhaustion that might ultimately improve clinical outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
刚刚
11完成签到 ,获得积分10
刚刚
ZZ发布了新的文献求助10
刚刚
666阳阳666完成签到 ,获得积分10
1秒前
靖哥哥发布了新的文献求助10
2秒前
李瑞卿完成签到 ,获得积分10
2秒前
dong应助宋宋采纳,获得10
2秒前
2秒前
babayaga发布了新的文献求助10
2秒前
4秒前
老迟到的盼海完成签到,获得积分20
6秒前
可爱的函函应助Myrna采纳,获得10
7秒前
7秒前
大模型应助Lily采纳,获得10
7秒前
左左发布了新的文献求助10
7秒前
el完成签到,获得积分10
7秒前
WWWUBING完成签到,获得积分10
8秒前
橙子发布了新的文献求助30
11秒前
慕青应助Amen采纳,获得10
11秒前
12秒前
可爱的函函应助甜甜沛蓝采纳,获得10
12秒前
英姑应助星期八采纳,获得10
12秒前
南兮完成签到,获得积分10
12秒前
13秒前
小二郎应助忧郁的灵竹采纳,获得10
13秒前
刘浩然完成签到,获得积分10
15秒前
17秒前
17秒前
17秒前
东耦完成签到,获得积分10
18秒前
19秒前
cyan完成签到,获得积分10
19秒前
zzzzzzzz完成签到,获得积分20
22秒前
FunHigh发布了新的文献求助10
22秒前
23秒前
23秒前
shunli完成签到,获得积分10
23秒前
WenjingziWang完成签到,获得积分10
23秒前
Amen发布了新的文献求助10
24秒前
Taemy完成签到,获得积分10
24秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Effective Learning and Mental Wellbeing 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975836
求助须知:如何正确求助?哪些是违规求助? 3520174
关于积分的说明 11201364
捐赠科研通 3256576
什么是DOI,文献DOI怎么找? 1798362
邀请新用户注册赠送积分活动 877539
科研通“疑难数据库(出版商)”最低求助积分说明 806426